A comprehensive review about the molecular structure of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Insights into natural products against …

EM Saied, YA El-Maradny, AA Osman, AMG Darwish… - Pharmaceutics, 2021 - mdpi.com
In 2019, the world suffered from the emergence of COVID-19 infection, one of the most
difficult pandemics in recent history. Millions of confirmed deaths from this pandemic have …

Could nanotechnology help to end the fight against COVID-19? Review of current findings, challenges and future perspectives

AT Yayehrad, EA Siraj, GB Wondie… - International Journal …, 2021 - Taylor & Francis
A serious viral infectious disease was introduced to the globe by the end of 2019 that was
seen primarily from China, but spread worldwide in a few months to be a pandemic. Since …

Chemical Composition of Honeysuckle (Lonicerae japonicae) Extracts and Their Potential in Inhibiting the SARS-CoV-2 Spike Protein and ACE2 Binding …

B Gao, L Zhu, Z Liu, Y Li, X He, X Wu… - Journal of Agricultural …, 2023 - ACS Publications
Honeysuckle (Lonicerae japonicae) has been used in functional tea products. The chemical
compositions of the water and ethanol extracts of honeysuckle were examined in the present …

A survey on computational methods in discovering protein inhibitors of SARS-CoV-2

Q Liu, J Wan, G Wang - Briefings in Bioinformatics, 2022 - academic.oup.com
The outbreak of acute respiratory disease in 2019, namely Coronavirus Disease-2019
(COVID-19), has become an unprecedented healthcare crisis. To mitigate the pandemic …

Effect of Carica papaya seed extract on IL-6 and TNF-α in human lung cancer cell lines-an In vitro study

A Padmapriya, S Preetha, J Selvaraj… - Research Journal of …, 2022 - indianjournals.com
Background Herbal medicine has been used for many years. Medicinal plants are a natural
source which has fewer side effects and has an ability to scavenge free radicals. Plants have …

Safety and Efficacy of COVID-19 Vaccine in Africa: Systematic Review

S Mengstu, A Beyene Berha - Infection and Drug Resistance, 2023 - Taylor & Francis
Background Coronavirus disease 2019 (COVID-19) pandemic scared the whole world at the
end of 2019, which is a communicable respiratory disease caused by severe acute …

Current clinical status of new COVID-19 vaccines and immunotherapy

D Nagpal, S Nagpal, D Kaushik, H Kathuria - Environmental Science and …, 2022 - Springer
Abstract COVID-19, caused by SARS-CoV-2, is a positive-strand RNA belonging to
Coronaviridae family, along with MERS and SARS. Since its first report in 2019 in Wuhan …

Defective ORF8 dimerization in SARS-CoV-2 delta variant leads to a better adaptive immune response due to abrogation of ORF8-MHC1 interaction

AM Chaudhari, I Singh, M Joshi, A Patel, C Joshi - Molecular Diversity, 2023 - Springer
In India, during the second wave of the COVID-19 pandemic, the breakthrough infections
were mainly caused by the SARS-COV-2 delta variant (B. 1.617. 2). It was reported that …

A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives

A Sezer, M Halilović-Alihodžić, AR Vanwieren… - Journal of Genetic …, 2022 - Springer
Background COVID-19 is an illness caused by severe acute respiratory syndrome
coronavirus 2. Due to its rapid spread, in March 2020 the World Health Organization (WHO) …

Seaweed sulfated polysaccharides against respiratory viral infections

M Jabeen, M Dutot, R Fagon, B Verrier, C Monge - Pharmaceutics, 2021 - mdpi.com
Respiratory viral infections have been a leading cause of morbidity and mortality worldwide.
Despite massive advancements in the virology field, no specific treatment exists for most …